Table Of Content
Individuals experiencing mental health issues should address them with healthcare professionals. Experts interviewed by Healthline expressed their frustration with the negative connotations of the term and reiterated that GLP-1 drugs are safe and effective. A review of the medical literature published in 2022 found that GLP-1 drugs resulted in “potent reductions” in alcohol and substance use. “You’re soothing yourself with all these bad foods and developing obesity, and so now you don’t feel like rewarding yourself with sugary food, and you’re in a bad mood.
Drug Summary
The mean baseline body weight was 107.5 kg, and mean BMI was 37 kg/m2. It is used together with diet and exercise to help control your blood sugar. This medicine is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart or blood vessel disease.
Heartburn
Those include stress and having too little biotin, iron, protein, or zinc. “We see it commonly with our weight loss surgery patients as well,” Dr. Ali says. In general, the mechanism likely has something to do with the way that weight loss medications affect the central nervous system, which can, in turn, affect mood and suicidal ideation risk, Rafi explained.
Are there resources to help my staff and me learn the injection technique?
Antacids like Gaviscon and Rennie help to neutralise your excess stomach acid, keeping it from irritating your food pipe and preventing your symptoms. As acid reflux is a common problem in people of all ages, there's lots of treatments to relieve your discomfort. If these aren’t working or your nausea is really getting you down you should reach out to your healthcare team.
Semaglutide and other anti-obesity medications are available as NHS-funded treatments only at a tier of weight-care management that often requires hospital support and that typically lasts for only two years. Although Miras suspects that most doctors will abide by the time limit on semaglutide use, either to adhere strictly to NICE guidance or because of health-service capacity issues, some might make exceptions depending on disease severity. Some studies have found large decreases in the risk of depression and anxiety; others found smaller but still positive effects. It seems to bend the curve on alcoholism and drug addiction and curb other addictive behaviors, as well — compulsive shopping and sex addiction, gambling and nail biting, smoking and skin picking. A compulsive nation has stumbled into what looks like a treatment for compulsion and one that happens to protect against some of the country’s biggest killers and curb some of its most pervasive pathologies and inner demons. Weakness and tiredness are common in patients taking weight loss medications, including Wegovy and Saxenda.
Can GLP-1 drugs Ozempic and Wegovy cause suicidal ideation, hair loss? - Medical News Today
Can GLP-1 drugs Ozempic and Wegovy cause suicidal ideation, hair loss?.
Posted: Mon, 08 Jan 2024 08:00:00 GMT [source]
It seems possible to imagine a future in which almost everyone is taking some variety of GLP-1 drug, and with a pretty good reason to do so. Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. He covers the Biden administration's public health agencies, including the federal response to infectious disease outbreaks like COVID-19. Doctors tell patients to stop eating before surgeries that require general anesthesia because of the risk it could be vomited up and end up in the lungs. However, if your symptoms persist, you should contact your doctor or pharmacist for further advice on how to prevent or reduce some of the side effects.
Related medical questions
Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with WEGOVY. Such monitoring may increase the risk of unnecessary procedures, due to the low test specificity for serum calcitonin and a high background incidence of thyroid disease. Significantly elevated serum calcitonin value may indicate MTC and patients with MTC usually have calcitonin values greater than 50 ng/L. If serum calcitonin is measured and found to be elevated, the patient should be further evaluated. Patients with thyroid nodules noted on physical examination or neck imaging should also be further evaluated. WEGOVY is contraindicated in patients with a personal or family history of MTC or in patients with MEN 2.
Novo Nordisk reserves the right to modify or cancel this program at any time. Refer patients to the full Prescribing Information for more details regarding injection and pen storage. Instruct patients to store the Wegovy® pen in the refrigerator between 36 °F and 46 °F (2 °C and 8 °C). If needed, before removing the pen cap, Wegovy® can be stored between 46 °F and 86 °F (8 °C and 30 °C) in the original carton for up to 28 days. Patients should keep Wegovy® in the original carton to protect it from light. Be sure to talk to your health care professional if you have questions about side effects.
Stomach (abdominal) side effects with GLP-1 agonist agents like Wegovy are common and well-known, but are usually mild and clear up in a few weeks. The most common side effect with Wegovy is nausea and occurs in about 44% of people. Others include diarrhea (30%), vomiting (24%), constipation (24%), stomach-area pain (20%), feeling bloated (7%), heartburn (5%), belching or gas (6%). In March 2024, the FDA also approved Wegovy to be used in adults to help reduce the risk of cardiovascular death, heart attack and stroke in people with cardiovascular (heart, blood vessel) disease in people with either obesity or overweight. While taking the medication, people can lose 5%-20% of their body weight in six to 12 months before weight loss plateaus. Although hair loss a shocking side effect, Dr. Vijaya Surampudi, assistant director of the UCLA weight management program in Los Angeles, said it’s relatively uncommon among people taking the medications.
If you have any kidney problems, tell your doctor before taking Wegovy. This medication can cause kidney problems to occur and may make existing kidney problems worse. In this case, your doctor can help determine whether Wegovy may be safe for you. If you notice diarrhea during your Wegovy treatment, talk with your doctor or pharmacist. For example, your doctor or pharmacist may suggest taking an OTC treatment such as Imodium (loperamide) to treat your diarrhea. If you have constipation during your treatment with Wegovy, talk with your doctor or pharmacist.
If the patient does not tolerate the maintenance 2.4 mg once-weekly dosage, then the dosage can be temporarily decreased to 1.7 mg once a week, for a maximum of 4 weeks. After four weeks, the dose should be increased to the maintenance 2.4 mg once-weekly dosage. Discontinue this medicine if the patient cannot tolerate the 2.4 mg dosage. You should stop using this medicine at least two months before you plan to get pregnant. Controlling diabetes is very important during pregnancy, as is gaining the right amount of weight. Even if you are overweight, losing weight during pregnancy could harm the unborn baby.
Counsel patients regarding the potential risk for MTC with the use of WEGOVY and inform them of symptoms of thyroid tumors (e.g. a mass in the neck, dysphagia, dyspnea, persistent hoarseness). Our Wegovy (semaglutide) Injection, for Subcutaneous Use Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. In 4-week intervals, increase the dose until a dose of 2.4 mg is reached.
No comments:
Post a Comment